Featured,Trends & Articles Study Shows Psilocybin Has the Potential to Reverse Alcohol-Induced Brain Damage By Dennis Mutua November 23, 2021 A recently released study is indicating that psilocybin, a compound found in magic mushrooms has the ability to reverse alcohol induced brain damages. Additionally, psilocybin also has the potential to reduce cravings for alcohol ...
Featured,Trends & Articles MYND Diagnostics Begins Clinical Research on Alzheimer’s Disease By Dennis Mutua November 18, 2021 Life sciences company focusing on novel drug development and pharmaceutical MYND Life Sciences Inc. (OTCMKTS: MYNDF) announced that its wholly owned subsidiary MYND Diagnostics has started a clinical research of an evaluation proc...
Featured,Trends & Articles Jaden Smith Describe His Experience With Psychedelics By Dennis Mutua November 15, 2021 American actor and rapper Jaden Smith has openly shared his experience with psychedelic substances and the healing properties they possess when it comes to mental health. Jaden made this revelation last week during a red talk tabl...
Featured,Trends & Articles Naropa University Introduces a Certificate Course in Psychedelic-Assisted Therapies By Dennis Mutua November 11, 2021 Colorado based Naropa University has unveiled a new certificate course in psychedelic-assisted therapies making it to the list of the few learning institutions across the world offering courses combining academic and clinical prac...
Featured Cybin, Inc. (NYSE: CYBN) is Emerging as an Early Market Leader in Booming Psychedelic Sector By editor November 10, 2021 This Recently Uplisted NYSE Stock Could Offer Investors the Best Way to Play this Rapidly Growing Market for Maximum Profit Potential The next huge potential opportunity in the biotech sector has arrived. This opportunit...
Featured,Shroom News Nova Mentis Seeking US Orphan Drug Designation for Psilocybin Therapy for Fragile X Syndrome By Dennis Mutua November 08, 2021 Biotechnology company focused on developing diagnostic and psychedelic based therapies Nova Mentis Life Sciences (CSE: NOVA) (OTCQB: NMLSF) has submitted an application seeking United Sates orphan drug status for its psychedelic t...
Featured,Trends & Articles U.S FDA Approves First Ever Psilocin Clinical Trial By Dennis Mutua November 03, 2021 Psychedelic company engaging psychedelic drug discovery and extraction to treat mental conditions Filament Health Corp. (NEO: FH) (OTCQB: FLHLF) announced having received an approval from the U.S Food and Drug Administration (FDA)...
Featured,Spotlight Stock Cava Healthcare Sells Patent of Using Psychedelics to Treat Dementia to Mynd Life Sciences By Dennis Mutua November 01, 2021 Early stage medical biotechnology company specializing in enhancing optimal health Cava Healthcare Inc. announced having entered into an agreement with Mynd Life Sciences Inc. (CSE: MYND) (OTCMKTS: MYNDF) to sell its right, title ...